Pregnant Sprague-Dawley rats and New Zealand White rabbits were exposed dermally to 0,10,25, and 75 mg/kg/day of monoethanolamine (MEA) for approximately 6 hr/day on Days 6 through 15 (rats) or 6 through 18 (rabbits) of gestation. A fifth dose group of 225 mg MEA/kg/day was evaluated in rats only. Dermal exposure of pregnant rats to 225 mg/kg/day and rabbits to 75 mg/ kg/day resulted in significant increases in the incidence of skin irritation/lesions and maternal body weight effects. In general, the dermal irritation observed at the high dose was progressive, beginning with erythema and leading to necrosis, scabs, and scar formation. Doses of 25 mg/kg/day to rabbits produced only minor irritation. Despite maternal effects observed in rats and rabbits, no evidence of developmental or fetal toxicity was observed at any dose level tested. Thus, it was concluded that MEA was not developmentally toxic following dermal application at exposure levels up to and including 225 mg/kg/day for rats and 75 mg/kg/ day for rabbits. © 1996 Society of Toxicology Monoethanolamine (MEA) is a colorless, hygroscopic liquid which is strongly alkaline and miscible with water, methanol, and acetone. MEA is used as a chemical intermediate and corrosion inhibitor, as well as in the production of cosmetics, soaps, hair waving solutions, detergents, agricultural sprays, paints, and polishes. In the majority of uses for MEA, dermal absorption is the primary route of potential human exposure.
kg (A.C.G.I.H., 1986). Klain et al. (1985) evaluated the dermal absorption of [
14 C]MEA in vivo using athymic nude mice with human skin grafts. The penetration rate of MEA through human grafts and mouse skin was similar, with I4 CO 2 derived from [ 14 C]MEA exhaled in the expired air as early as 30 min postdosing. At 24 hr postdosing, radioactivity was widely distributed throughout the body with approximately 25% of the applied dose distributed to the liver, approximately 19% excreted as 14 CO 2 in the expired air, and 12-18% remaining in the dermis.
MEA may be irritating to the skin of animals and humans. Undiluted MEA produced a burn when applied to the skin of rabbits for 4 hr and is therefore considered corrosive (Cosmetic Ingredient Review, 1983) . Marked redness and "infiltration" with no burn were observed when undiluted MEA was applied to the skin of human volunteers for 1.5 hr (Beard and Noe, 1981) , while application of various dilutions of MEA (1-30%) to the skin of rabbits resulted in varying degrees of irritation ranging from slight redness to burns (Cosmetic Ingredient Review, 1983) .
The teratogenic potential of MEA has been examined previously. Pereira et al. (1987) tested MEA using the Chernoff-Kavlock postnatal mouse screening assay. This method assesses embryonic, fetal, and neonatal toxic responses following high-dose exposure (1 dose level) of pregnant mice treated during the period of major organogenesis and is used primarily to set priorities for further testing. The number of pups born live, pup weights at birth, and growth and survival to postnatal Day 3.5 are used as the primary measures of potential to cause adverse developmental effects. In this assay oral administration of 850 mg MEA/kg/day to pregnant CD-I mice on Days 6-15 of gestation resulted in 16% mortality of maternal animals and reduced numbers of viable litters. Administration of MEA did not affect litter size, percentage survival of pups, birth weight, or weight gain of pups. Based on the results of this assay, MEA was considered to be of low priority for further testing. Mankes (1986) reported evidence of embryo toxicity as indicated by increases in the number of "malformed" pups delivered by cesarean section from Long-Evans rats following administration of MEA by gavage on Days 6-15 of gestation at doses of 50, 300, or 500 mg/kg/day. However, the malformations reported, with the exception of hydronephrosis, including ranting, hydroureter, and unspecified skeletal variations, are more commonly considered developmental variations rather than evidence of teratogenicity.
In a subsequent study, Hellwig (1994, unpublished report of BASF. Ludwigshafen, Germany) utilized more conventional methods to evaluate the effects of MEA on embryonic, fetal, and perinatal development in Wistar rats following oral gavage at dose levels of 40, 120, and 450 mg/kg/day on Days 6-15 of gestation. Significant decreases were reported in the mean body weights of dams administered 450 mg ME A/kg/day on gestation Days 15, 17, and 20 and on postpartum Days 0, 4, 7, and 21 with corresponding decreases in maternal feed consumption on gestation Days 6-8 and 17-20. Body weight gains of these dams were also decreased during gestation Days 15-20. No evidence of maternal toxicity was noted at dose levels of 40 or 120 mg/kg/day. Contrary to findings reported by Mankes (1986) , no signs of developmental toxicity or increased incidences of malformations or alterations were observed in fetuses or pups at doses up to and including 450 mg MEA/kg/day.
As dermal contact has been determined to be a likely route of potential human exposure to MEA, the studies presented herein were conducted in order to evaluate the teratogenic potential of MEA in rats and rabbits following dermal exposure. The rat study was conducted at the Toxicology Research Laboratory, The Dow Chemical Co. (Midland, MI) and the rabbit study was conducted at the Bushy Run Research Center, Union Carbide Chemicals and Plastics Inc. (Export, PA). Both studies were conducted to meet the requirements of Good Laboratory Practice for the Food and Drug Administration, the Environmental Protection Agency, and the Organization for Economic Cooperation and Development.
MATERIALS AND METHODS

Animals.
Male and female VAF/Plus (Virus Antibody Free) CD rats were obtained from Charles River Breeding Laboratories, Inc. (Kingston, NY) and female SPF (Specific Pathogen Free) New Zealand White rabbits were obtained from Hazelton Research Products, Inc. (Denver, PA) and allowed to acclimate to laboratory conditions for approximately 2 weeks prior to breeding. Animals were housed in the respective laboratories in wire-bottom cages in rooms designed to maintain temperature at approximately 22°C for rats and 20°C for rabbits. Relative humidity was maintained at 40-60%, with a 12-hr lightdark photocycle. Virgin female rats (approximately 250-300 g) were bred overnight with adult males of the same strain (one male:one female) and Day 0 of gestation designated as the day on which sperm were detected in the vaginal smear. Rabbits (approximately 3.0-4.0 kg) were mated (1 female:2 males) to "proven" males. The day on which copulation was observed was considered gestation Day 0. Animals were randomly assigned to test groups according to their Day 0 of gestation. Feed 3 and municipal tap water were available ad libitum throughout the study.
Test chemical. MEA was obtained from The Dow Chemical Co. (Plaquemine, LA) for the rat study and Union Carbide Chemicals and Plastics Company Inc. (North Seadrift, TX) for the rabbit study. Analysis by gas chromotography using flame ionization detection indicated a purity of 100% for both the rat and rabbit studies.
Experimental design. Groups of 30-45 rats and 15 rabbits were exposed dermally to MEA for 6 hr per day at dose levels of 0, 10, 25, and 75 mg/kg/day on Days 6-15 (rats) or 6-18 (rabbits) of gestation. A fifth dose group of 225 mg MEA/kg/day was evaluated in rats only. Dose levels selected for these studies were chosen based upon the results of dermal range-finding and teratology probe studies conducted in rats and rabbits. Deionized (rats) or Milli-Q (rabbits) water was used as the dosing vehicle as MEA is water-soluble, water does not produce skin irritation, and its absorption would not confound the results of the studies. For rats, the test material was applied directly to the backs (clipped free of hair) of the animals and the exposure site was occluded with an absorbant gauze pad followed by nonabsorbant cotton. An elastic bandage was wrapped securely around the animal to hold the patch in place and to prevent accidental ingestion of the test material via grooming during the exposure. Care was taken not to wrap the animals too tightly so as not to cause discomfort or breathing problems. After completion of each daily exposure, the bandage and patch were removed and the exposure site was wiped with a waterdampened towel to remove residual test material. For rabbits, the test material was applied in a similar manner and the exposure site was occluded with a sterile gauze pad and a specially designed Lycra-Spandex jacket fitted with Velcro closures and lined with polyethylene film. After each exposure, the jackets and gauze pads were removed and the application site was wiped as described for the rats. Control groups were administered the vehicle (deionized or Milli-Q water) in a similar manner. The volume of dosing solution administered to each rat (1 ml/kg) was adjusted daily based upon the animals current body weight, while for rabbits the dosing volumes (2 ml/kg) remained constant and were calculated based upon the does' body weight on gestation Day 6. Concentrations of MEA in the dosing solutions (1-22.5% for rats and 0.5-3.75% for rabbits), stability throughout the dosing period, and homogeneity of the dosing solutions were confirmed analytically.
Maternal and fetal observations. All animals were observed daily for treatment-related effects. The site of test material application was assessed for indications of irritation following each daily treatment. In the rabbit study, skin irritation also was evaluated once daily during the postdosing period. Maternal body weights were recorded on gestation Days 0, 3, 6-16, and 21 for rats and Days 0, 6, 9, 12, 15, 18, 24, and 29 for rabbits. Feed (rats and rabbits) consumption and water (rats only) consumption were determined. Immediately prior to scheduled cesarean section, blood was obtained from the central auricular artery of all surviving rabbits for hematologic determinations. At cesarean section on Day 21 (rats) or Day 29 (rabbits), weights of the maternal liver, kidneys, and gravid uteri were recorded as well as the number of corpora lutea and the numbers and position of implantations, resolutions, and live or dead fetuses. Uteri with no visible implantations were stained with a 10% sulfide solution (Kopf et al., 1964; Salewski, 1964) and examined for evidence of early resorptions.
All fetuses were weighed and examined for evidence of external alterations and palate closure. At least one-half of the rat fetuses and all of the rabbit fetuses in each litter were examined for visceral alterations (Staples, 1974) . The sex of all live fetuses was determined. The heads of rat fetuses not selected for skeletal examination and one-half of all rabbit fetuses Bred CD rats were exposed dermally to MEA for 6 hr/day on Days 6-15 of gestation. 6 Mean + SD. * Statistically different from control (a = 0.05).
were removed, placed in Bouin's solution, and subsequently sectioned and examined for craniofacial defects (Wilson, 1965; Van Julsingha and Bennet, 1977) . All fetuses were eviscerated and stained with alizarin red-S (Dawson, 1926; Crary, 1962) . Skeletal examinations were conducted on all rabbit fetuses, but on only the rat fetuses not selected for Bouin's examination.
Statistical evaluation. Continuous data were evaluated for homogeneity of variance using Bartlett's test (Winer, 1971 ) for the rat study or Levene's test (Levene, 1960) for the rabbit study. Based upon the outcome of these tests, a parametric or nonparametric analysis of variance (ANOVA) was performed. If the ANOVA was significant, analysis by Dunnett's test (Steel and Torrie, 1960) , the Wilcoxen Rank-Sum test with Bonferroni's correction (Miller, 1966) , or a pooled t test was performed as appropriate. The level of statistical significance was set a priori at a = 0.05.
Nonparametric data for the rat study were statistically treated using the Kruskal-Wallis test followed by the Mann-Whitney U test (Sokal and Rohlf, 1969) , when appropriate. Incidence data for rabbits were compared using Fischer's exact probability test (Siegel, 1956) , while incidence data for rats was analyzed using the Wilcoxon test as modified by Haseman and Hoel (1974) . Fetal sex ratios for rats were analyzed using a binomial distribution test (Steel and Torrie, 1960) .
RESULTS
Rats.
Rats administered 225 mg MEA/kg/day exhibited a treatment-related increased incidence of skin irritation at the site of exposure. In general, the dermal irritation followed a progression, beginning with erythema and leading to necrosis, scabs, and scar formation. No significant dermal irritation or lesions were observed among rats administered lower doses of MEA. There were no postmortem treatment-related effects observed in any dose group. No significant differences were observed in the feed or water consumption of MEA exposed rats relative to controls (data not presented). The body weight gain of rats given 225 mg MEA/kg/day was significantly decreased during the exposure period (Table 1) . No effect on weight gain was observed in dams treated with lower levels of MEA.
No effects on liver or kidney weights were observed at any dose level (data not presented). Despite maternal effects observed'among dams given 225 mg/kg/day, reproductive parameters among MEA exposed rats were unaffected at this or lower dose levels ( Table 2) .
There were no differences in pregnancy rate, number of corpora lutea, number of implantations, resorptions, litter size, number of dead fetuses, fetal sex ratio, fetal body weight, or gravid uterine weight among any of the dose groups when compared to controls.
A summary of the incidence of external, visceral, and skeletal variations and malformations among litters of rats is presented Table 3 . There were no treatment-related increases in the incidence of variations or malformations observed externally, viscerally, or at skeletal examination by individual category, or in total variations or malformations when compared to controls. Among controls, the following types of malformations were observed: microphthalmia, retroesophageal right subclavian artery, and an extra cervical rib. No malformed fetuses were observed in the 10 mg/kg/day dose group. Malformations observed in the 25 mg MEA/kg/day dose group included retroesophageal right subclavian artery and an extra cervical rib. A single fetus was malformed in the 75 mg MEA/ kg/day dose group. This fetus had multiple craniofacial malformations consisting of micrognathia, cleft lip and 159 (38) 51 (90) 1 (1) One fetus inadvertently not examined externally. * One fetus examined both viscerally and skeletally. c A single fetus may be represented more than once in listing individual defects. Bred rabbits were exposed dermally to MEA for 6 hr/day on Days 6-18 of gestation. b Mean ± SD. soft palate, and aglossia. No malformations were observed in fetuses from dams administered 225 mg MEA/kg/day.
Rabbits. Rabbits administered 75 mg/kg/day of MEA exhibited severe skin irritation (erythema, edema, ecchymosis, necrosis, exfoliation, and crusting) at the site of exposure. Subsequent to the dosing period, exfoliation, crusting, and areas of necrosis persisted. The skin of the majority of these rabbits began to heal as evidenced by scab formation late in the gestation period. Crusting, transient erythema, and edema were noted in a few rabbits administered 25 mg MEA/kg/day. No significant dermal irritation or lesions were observed among rabbits administered 10 mg MEA/kg/day.
No females died, aborted, delivered early, or were removed from the test during the study. There were also no significant treatment-related effects observed on feed consumption, hematologic parameters, or kidney and liver weights of MEA-exposed rabbits at any dose level tested (data not presented). Body weight and body weight gain data are presented in Table 4 . Although no statistically identified changes were observed in either parameter, the average body weight gain of high-dose rabbits over the course of gestation was decreased when compared to that of the control and other dose groups, mainly due to weight loss or very little weight gain during the treatment period. 24 (14) 19 (93) 124 (14) 98 (93) 0 0 8 (4) 6 (27) 2 (2) 2 (13) MEA (mg/kg/day) 10 25 fetuses (number litters) examined 110 (14) 110 (14) 110 (14) Fetuses (litters) affected 0 0 38 (11) 35 (79) 110 (14) 100 (100) 0 0 10 (5) 9 (36) 3 (2) 3 (14) 109 (13) 109 (13) 109 (13) 0 0 15 (8) 14 (62) 104 (13) 96 ( (14) 122 (14) 122 (14) 0 0
23 (11) 19 (79) 117 (14) 95 (100) 0 0 10 (4) 8 (29) 2(2) 2(14)° A single fetus may be represented more than once in listing individual defects.
No treatment-related effects were observed on reproduc-tissue depression and missing lung lobe. Malformations obtive parameters (Table 5) including pregnancy rate, number served in fetuses from the 75 mg/kg/day dose group litters of corpora lutea, number of implantations, resorptions, litter included the following: dilated lateral cerebral ventricle with size, number of dead fetuses, fetal sex ratio, fetal body tissue depression, missing lung lobe, diagonally displaced thoweight, or gravid uterine weight among MEA exposed rab-racic centra, missing thoracic arch, and a single missing rib. bits at any dose level when compared to controls.
A summary of the incidence of external, visceral, and skele-DISCUSSION tal variations and malformations among litters of rabbits is presented in Table 6 . There were no statistically or biologically Dermal exposure of rats or rabbits to MEA via occluded significant treatment-related differences in the incidence of any cutaneous application, at doses which produced severe mafetal variation or malformation, or in the number of malformed ternal dermal irritation, did not produce evidence of embryofetuses in any dose group. Among control litters the following toxicity, fetotoxicity, or teratogenicity. Exposure of pregnant types of malformations were noted: ventricular septal defect, rats to 225 mg MEA/kg/day resulted in significant increases common opening at entry of the vessels of the heart, missing in the incidence of skin irritation/lesions and a significant lung lobe, missing gallbladder, and extra lumbar centrum and decrease in body weight gain over the exposure period. Dearches. Malformations observed in litters from rabbits given spite significant maternal effects observed in rats given 225 10 mg/kg/day included dilated lateral cerebral ventricle with mg MEA/kg/day, no embryonal or fetal effects were obtissue depression, missing lung lobe, missing gallbladder, mal-served in litters from these dams. No significant maternal aligned or fused thoracic centra, extra lumbar centrum and toxicity, including dermal irritation, or embryonal/fetal toxarches, and fused ribs. Limited numbers of malformations noted icity was observed in rats administered doses of 10, 25, or at 25 mg/kg/day included dilated lateral cerebral ventricle with 75 mg MEA/kg/day. In rabbits, administration of MEA at a dose of 75 mg/kg/day during pregnancy produced severe skin irritation and body weight losses over the dosing period. Application of 25 mg MEA/kg/day produced very minor irritation in a few animals and 10 mg MEA/kg/day produced no signs of maternal toxicity. Again, despite the maternal toxicity noted, no evidence of developmental effects or fetotoxicity was observed'at any dose level. The dermal irritation observed in these studies is consistent with the known corrosiveness of MEA (Cosmetic Ingredient Review, 1983) .
The lack of developmental effects or fetotoxicity in these dermal studies corroborates the findings of Hell wig (1994, unpublished report of BASF, Ludwigshafen, Germany) in which no developmental toxicity was observed in pregnant Wistar rats administered up to 450 mg MEA/kg/day via gavage. The results of these studies, however, contrast with those reported by Mankes (1986) , in which a number of developmental effects were noted in Long-Evans rats orally dosed with 3=50 mg MEA/kg/day. Several factors may account for this. The latter study was more exploratory in nature, being designed primarily to examine the role of in utero position in modulating developmental effects, rather than providing data on MEA for human risk assessment. Additionally, the classification of certain fetal effects as malformations was atypical (e.g., runting was considered a malformation) and no dose-response relationship was observed for any of the "malformations" reported.
In conclusion, no evidence of developmental or fetal toxicity was observed following dermal exposure of pregnant rats and rabbits to maternally toxic dosages of MEA. Evidence of maternal toxicity was evidenced primarily as skin irritation at doses of 225 mg MEA/kg/day in rats and 25 or 75 mg MEA/kg/day in rabbits. Significant decreases in body weight gain over the dosing period were noted in rats administered 225 mg MEA/ kg/day and were apparent, although not statistically identified, in rabbits administered 75 mg MEA/kg/day. Therefore, the noobserved-effect level (NOEL) for maternal toxicity in rats was 75 mg/kg/day and in rabbits was 10 mg/kg/day. The NOEL for embryonal and fetal toxicity was 225 mg/kg/day in rats and 75 mg/kg/day in rabbits, the highest dose level tested in each study.
